MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Clinical analysis of patients with servical dystonia who Botulinum toxin injection is performed: 10 years experience of Ege University Neurology Department of Movement Disorders Clinic

    A. Acarer, S. Ciftci, Z. Colakoglu (Izmir, Turkey)

    Objective: In this study, it is aimed to analysis of clinical features and  treatment efficiency  in patients with servical dystonia who are performed Botulinum injection…
  • 2017 International Congress

    Two sides of a Rare Coin- First report of Rapid onset dystonia-parkinsonism (RDP) and Alternating Hemiplegia of Childhood (AHC) with paroxysmal dystonia from India.

    P. Agarwal, S. Ravat (Mumbai, India)

    Objective: To report clinical findings in two Indian cases: 1. RDP and 2. AHC with paroxysmal dystonia. These two rare conditions are allelic disorders caused by…
  • 2017 International Congress

    Pregnancy and Parkinson’s disease: A review and update

    M. Seier, A. Hiller (Portland, OR, USA)

    Objective: To investigate the literature on pregnancy in the setting of Parkinson’s disease (PD) in order to better understand and treat women who become pregnant.…
  • 2017 International Congress

    Multidisciplinary intensive outpatient rehabilitation program for patients with advanced Parkinson’s disease: feasibility and primary proof of concept

    T. Gurevich, T. GAIL, n. choen, o. KADURRI, L. SHTRAIFLER, I. BADICHI, N. RIPS CASSERI (tel aviv, Israel)

    Objective: To describe as a proof of concept our experience with a multidisciplinary, intensive out-patient rehabilitation program (MIOR) for advanced PD patients. Background: Intensive, multi-dimensional…
  • 2017 International Congress

    Inpatient care for stiff person syndrome in the United States: A nationwide readmission study

    J. Crispo, D. Thibault, Y. Fortin, A. Willis (Sudbury, ON, Canada)

    Objective: To describe national inpatient care for stiff person syndrome (SPS) in the United States and characterize all-cause 30-day readmission. Background: SPS is a rare…
  • 2017 International Congress

    Effects of a Parkinson-Specific, Interdisciplinary Approach, To Inpatient Rehabilitation

    C. Benedict, D. Fredericks, C. Manganiello, H. Herrstrom, D. Schmitt, K. Lyons (Topeka, KS, USA)

    Objective: To demonstrate the effects of an interdisciplinary team approach in the evaluation and treatment of Parkinson’s disease (PD) patients, during inpatient rehabilitation. Background:  PD…
  • 2017 International Congress

    Does the side of onset affect motor and non-motor symptoms in Parkinson’s disease?

    J. Silva, A. D'Abreu (Campinas, Brazil)

    Objective: To assess the association between motor and non-motor symptoms of Parkinson’s Disease (PD) and side of onset considering hand dominance. Background: PD motor symptoms…
  • 2017 International Congress

    Open label study of cannabidiol in Parkinson disease

    M. Leehey, Y. LIU, C. EPSTEIN, F. HART, J. BAINBRIDGE, M. COOK, S. SILLAU, Z. BAUD, H. NEWMAN (AURORA, CO, USA)

    Objective: To determine if cannabidiol (CBD) is tolerated and effective in Parkinson disease (PD) and the dosage needed for a Phase 2 randomized controlled trial.…
  • 2017 International Congress

    Observational study of the effectiveness and tolerability of rotigotine+levodopa therapy in older vs younger Parkinson’s disease patients

    D. Woitalla, M. Asgharnejad, L. Joeres, J.-C. Schuller, K.R. Chaudhuri (Bochum, Germany)

    Objective: Prospective non-interventional study conducted in routine clinical practice (PD0013; NCT02227355) to compare effectiveness and tolerability of rotigotine+levodopa (RTG+Ldopa) in Parkinson’s disease (PD) patients aged…
  • 2017 International Congress

    Sentence comprehension in Slovak speaking patients with Parkinson´s disease – preliminary results

    A. Kušnírová, J. Marková, Z. Košutzká, M. Egryová, M. Pápayová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

    Objective: The aim of our research was to analyze comprehension of various syntactic constructions in Slovak-speaking PD-ND patients . We were particularly interested in exploring…
  • « Previous Page
  • 1
  • …
  • 137
  • 138
  • 139
  • 140
  • 141
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley